Stocks · Health care · Pharmaceutical Preparations

AbbVie

ABBV Clue Score27
United States Fiscal year ends December CIK 0001551152 Results filed 30 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Nicholas Donoghoe
14 Aug 2026
EVP, Chief Bus/Strat Officer
Sold after exercise
32,710
$250.00
$8.18M
David Ryan Purdue
4 Mar 2026
SVP, Controller
Sell
5,230
$233.56
$1.22M
Perry C Siatis
2 Mar 2026
EVP, GC and Secretary
Sold on a plan
2,600
$235.26
$611.68K
Perry C Siatis
2 Mar 2026
EVP, GC and Secretary
Sold on a plan
10,291
$234.66
$2.41M
Perry C Siatis
2 Mar 2026
EVP, GC and Secretary
Sold on a plan
5,777
$233.51
$1.35M
Perry C Siatis
25 Feb 2026
EVP, GC and Secretary
Sold after exercise
22,381
$230.00
$5.15M

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 2
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 516,798
History held since 14 Dec 2012